Alzheimer's disease is the most common form of dementia in the elderly. Currently, there is no established standard treatment for this disease; therefore, the treatment of Alzheimer's disease will be a major challenge for physicians in the next decade in order to ameliorate quality of life of patients and reduce the costs for the communities.

doi.org/10.3233/JAD-140016, hdl.handle.net/1765/83600
Journal of Alzheimer's Disease
Department of Internal Medicine

Mattace Raso, F. (2014). Is memantine + acetylcholinesterase inhibitor treatment superior to either therapy alone in Alzheimer's disease?. Journal of Alzheimer's Disease (Vol. 41, pp. 641–642). doi:10.3233/JAD-140016